Key Takeaways from the 340B Coalition Summer Conference

The 340B Coalition, the umbrella group for the 13 national trade associations that represent the providers participating in the 340B drug discount program, held its annual meeting July 15-17 in Washington, D.C. In this month’s column, I will share … [Read more...]

Why the Election Results Matter For 340B Hospitals

To say it has been a challenging two years for providers participating in the 340B drug discount program would be an understatement. This once-obscure federal program, which was enacted by Congress on an almost unanimous vote 26 years ago, has become … [Read more...]

The 340B Drug Discount Program Is Fulfilling Its Original Purpose

The debate over the future of the 340B drug pricing program has reached a critical new phase. Several members of Congress introduced legislation that would make dramatic changes in the 26-year-old statute, Congress is holding hearings on the program … [Read more...]

Setting the Record Straight on Drug Discounts

We recently celebrated the 25th anniversary of the 340B Drug Pricing Program, signed into law by then-President George H.W. Bush. With strong bipartisan support, the law requires drug companies to discount their prices when they sell to clinics, … [Read more...]

No, Health Costs Aren’t Rising Because of Drug Discount Programs

Why would a group that claims to hate government waste want to tear down a small federal health-care program that saves taxpayers money? We should first start by following the money. In The Hill, the group Citizens Against Government Waste tore … [Read more...]

This Drug Discount Program is Good for Americans. But PHARMA Wants to Gut it

Sticker shock over the cost of drugs isn’t going away any time soon. Drug prices spiked 7 percent last year, the highest rate since 1992. Compare that with the modest increase of just 0.8 percent in hospital care costs. So why is the … [Read more...]

340B: A Program Worth Fighting For

The federal 340B drug discount program is essential to helping safety net providers meet their missions to treat the underserved. The program is under heavy attack in Washington, DC by the drug industry, which wants to gut it to maximise profits. At … [Read more...]

Three Proposals That Would Kill the 340B Program

In the December issue of Evidence-Based Oncology, Rena M. Conti, PhD; Peter B. Bach, MD, MAPP; and Michael Kolodziej, MD, laid out 3 proposals to reform the 340B Drug Discount Program. However, their prescriptions would effectively cause the … [Read more...]

Setting the Record Straight on Drug Shortages

John Goodman of the National Center for Policy Analysis (NCPA) says in a June 8 Health Affairs Blog entry that the Public Health Service 340B drug discount program is part of a "web of [federal] regulations that are preventing life saving drugs from … [Read more...]